In essence, AMPK activation generates a metabolically unfavorable environment for tumor survival under therapeutic stress: it suppresses growth, promotes apoptosis, and diminishes the tumor’s ability to recover post-treatment. This evidence concerns the gene PRKAB1 and neoplasm.